Vericel Corp. (VCEL)
37.38
+0.35
(+0.95%)
USD |
NASDAQ |
Jun 10, 16:00
37.44
+0.06
(+0.16%)
After-Hours: 20:00
Vericel Max Drawdown (5Y) : 73.97% for May 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| May 31, 2026 | 73.97% |
| April 30, 2026 | 73.97% |
| March 31, 2026 | 73.97% |
| February 28, 2026 | 73.97% |
| January 31, 2026 | 73.97% |
| December 31, 2025 | 73.97% |
| November 30, 2025 | 73.97% |
| October 31, 2025 | 73.97% |
| September 30, 2025 | 73.97% |
| August 31, 2025 | 73.97% |
| July 31, 2025 | 73.97% |
| June 30, 2025 | 73.97% |
| May 31, 2025 | 73.97% |
| April 30, 2025 | 73.97% |
| March 31, 2025 | 73.97% |
| February 28, 2025 | 73.97% |
| January 31, 2025 | 73.97% |
| December 31, 2024 | 73.97% |
| November 30, 2024 | 73.97% |
| October 31, 2024 | 73.97% |
| September 30, 2024 | 73.97% |
| August 31, 2024 | 73.97% |
| July 31, 2024 | 73.97% |
| June 30, 2024 | 73.97% |
| May 31, 2024 | 73.97% |
| Date | Value |
|---|---|
| April 30, 2024 | 73.97% |
| March 31, 2024 | 73.97% |
| February 29, 2024 | 73.97% |
| January 31, 2024 | 73.97% |
| December 31, 2023 | 73.97% |
| November 30, 2023 | 73.97% |
| October 31, 2023 | 73.97% |
| September 30, 2023 | 73.97% |
| August 31, 2023 | 73.97% |
| July 31, 2023 | 73.97% |
| June 30, 2023 | 73.97% |
| May 31, 2023 | 73.97% |
| April 30, 2023 | 73.97% |
| March 31, 2023 | 73.97% |
| February 28, 2023 | 73.97% |
| January 31, 2023 | 75.56% |
| December 31, 2022 | 79.64% |
| November 30, 2022 | 84.14% |
| October 31, 2022 | 87.75% |
| September 30, 2022 | 87.75% |
| August 31, 2022 | 87.75% |
| July 31, 2022 | 91.89% |
| June 30, 2022 | 92.40% |
| May 31, 2022 | 94.41% |
| April 30, 2022 | 94.94% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Marker Therapeutics, Inc. | 99.42% |
| Krystal Biotech, Inc. | 53.42% |
| TG Therapeutics, Inc. | 93.19% |
| Gyre Therapeutics, Inc. | 98.99% |
| ACADIA Pharmaceuticals, Inc. | 77.18% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -25.46 |
| Beta (5Y) | 1.122 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 41.44% |
| Historical Sharpe Ratio (5Y) | -0.3268 |
| Historical Sortino (5Y) | -0.6026 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 18.21% |